Table 4.
PGI-I outcome | Moderate symptoms (n=88) | Severe symptoms (n=73) | |||
N (%) | Change | Missing | N (%) | Change | |
Very much better | 3 (3.4) | 6.5 (−50.7 to 63.7) | 1 | 3 (4.1) | 18 (1.7 to 34.3) |
Much better | 30 (34.1) | 5.6 (3.7 to 7.5) | 1 | 19 (26.0) | 13.5 (10.5 to 16.5) |
A little better | 33 (37.5) | 3.2 (1.7 to 4.8) | 0 | 32 (43.8) | 7.1 (5.3 to 9.0) |
No change | 19 (21.6) | 1.3 (−1.7 to 4.3) | 0 | 19 (26.0) | 4.9 (2.3 to 7.6) |
A little worse | 3 (3.4) | −5.0 (−31.0 to 20.9) | 0 | 0 (0.0) | – |
These results are stratified by baseline symptom severity on the IPSS: moderate symptoms are scores of 8–19 and severe symptoms are scores of ≥20. Change in IPSSs were estimated by comparing symptom scores between baseline and 6 weeks. Mean change and 95% CIs are presented. Outcomes are inverted so that positive changes reflect symptom improvement. The PGI-I category ‘a little better’ reflects the MID for both questionnaires. None of the participants scored ‘much worsened’ or ‘very much worsened’ on the PGI-I.
IPSS, International Prostate Symptom Score; MID, minimal important difference; OAB-q SF, Overactive Bladder Questionnaire short form; PGI-I, Patient Global Impression of Improvement.